Revenio: Holistic value creation on the horizon
Under the iCare brand, Revenio offers world-class tonometers, fundus imaging devices and perimeters. In recent years, the company has added software solutions to its offering, moving from being an equipment provider to a holistic eye diagnostics solution provider. The core business is growing very profitably, the market has sound growth drivers, and the company’s products have strong competitive advantages. At the same time, the company is creating future growth by developing new growth initiatives, of which Revenio has an excellent track record.
Revenio Group
Revenio is a medical technology company. Within the Group, there is research and development of pressure measurement technology that is used in the treatment of a number of diseases such as glaucoma, osteoporosis, skin cancer, and asthma. Operations are held worldwide and are run via most subsidiaries, each with a business focus. The company's head office is located in Vantaa.
Read more on company pageKey Estimate Figures18.03.2023
2022 | 23e | 24e | |
---|---|---|---|
Revenue | 97.0 | 111.4 | 129.6 |
growth-% | 23.10 % | 14.88 % | 16.34 % |
EBIT (adj.) | 30.9 | 34.0 | 39.5 |
EBIT-% (adj.) | 31.84 % | 30.48 % | 30.50 % |
EPS (adj.) | 0.86 | 0.98 | 1.15 |
Dividend | 0.36 | 0.42 | 0.55 |
Dividend % | 0.93 % | 1.54 % | 2.02 % |
P/E (adj.) | 44.64 | 27.86 | 23.81 |
EV/EBITDA | 30.64 | 19.18 | 16.12 |